Polymorphic genes have been linked to the risk of acute lymphoblastic leukemia (ALL). Surrogate markers for a low burden of early childhood infections are also related to increased risk for developing childhood ALL. It remains uncertain, whether siblings of children with ALL have an increased risk of developing ALL. This international collaboration identified 54 sibships with two (N ¼ 51) or more (N ¼ 3) cases of childhood ALL (ages o18 years). The 5-year event-free survival for 61 patients diagnosed after 1 January 1990 was 0.83 ± 0.05. Ages at diagnosis (Spearman correlation coefficient, r S ¼ 0.41, P ¼ 0.002) were significantly correlated, but not WBCs (r S ¼ 0.23, P ¼ 0.11). In 18 sibships with successful karyotyping in both cases, six were concordant for highhyperdiploidy (N ¼ 3), t(12;21) [ETV6/RUNX1] (N ¼ 1), MLL rearrangement (N ¼ 1) or t(1;19)(q23/p13) (N ¼ 1). Eleven sibships were ALL-subtype concordant, being T-cell ALL (T-ALL) (N ¼ 5, of a total of six sibships, where the first-born had T-ALL) or B-lineage ALL belonging to the same cytogenetic subset (N ¼ 6), a finding that differs significantly from the expected chance distribution (j: 0.58; Po0.0001). These data indicate strong genetic and/or environmental risk factors for childhood ALL that are restricted to specific ALL subtypes, which must be taken into account, when performing epidemiological studies to reveal etiological factors.
Introduction
Before 18 years of age, approximately 1 in 1600-2000 children will develop acute lymphoblastic leukemia (ALL), the most common childhood cancer.
1,2 Recent genome-wide association studies of children with ALL have identified a few ALLpredisposing genetic polymorphisms (for example, ARID5B, CEPBE and IKZF1) that are associated with growth regulation, hematopoiesis, lymphocyte development and less than two-fold increased risk of developing ALL. [3] [4] [5] [6] Some of the regions (for example, IKZF1 and CDKN2A) are frequently inactivated in hematopoietic malignancies. Previously, candidate-gene approaches have identified several other ALL-predisposing polymorphic genes in pathways affecting detoxification, 7 folate metabolism 8 or responses to infections, 9, 10 and these are associated with a two-to three-fold increased risk of ALL. High socio-economic standards accompanied by delayed exposure to common infections during early childhood have also been linked to an increased risk of developing childhood ALL. 2, [11] [12] [13] [14] Consequently, siblings of children with ALL would be expected to have an increased risk of ALL. Indeed, two death-certificate studies [15] [16] [17] and a US Childhood Cancer Survivor Study 18 indicated a two-fold increased risk of leukemia among siblings of children with leukemia. However, a Nordic population-and register-based study of 42 000 siblings of children with cancer revealed only two non-twin sibships with two leukemia cases compared with the five leukemia sibships that were expected by chance. 19 None of studies systematically adjusted for subtypes of leukemia, sibship sizes and/or completeness of follow-up of all siblings until the age of 18 years. Moreover, it is uncertain whether other severe bone-marrow diseases, such as stage IV neuroblastomas 20 or leukemoid reactions could have been misclassified as leukemia in these studies.
An exploration of the true incidence of sibships with non-twin multiple childhood ALL cases is hampered by the extreme rarity of such families. As an alternative, the present international study was performed to address two independent hypotheses that could be explored by studying families with two or more cases of childhood ALL in a sibship. First, if there is a familial propensity to develop the same subtypes of ALL, there should be a significantly increased subtype concordance within the families. Second, if there is a maternally driven protective mechanism against recurrence of the subsets of ALL commonly initiated prenatally (most notably high-hyperdiploid or ETV6-RUNX1-positive cases), the concordance rate could be significantly lower than that expected by chance. 21 
Materials and methods
We searched http://www.ncbi.nlm.nih.gov/pubmed/ for papers published between 1951 and 2009 with medical subject headings and text-words specific for leukemia combined with familial, siblings or sibships, limiting the search to the age group 0-18 years. Additional papers were identified through the reference lists of the identified publications (Supplementary 1).
The minimum inclusion criteria were that the leukemia cases in a sibship were ALL, and that at least the ages at diagnosis were available. If the articles lacked data on patients' ages at diagnosis (primarily older publications), we attempted to contact the first authors to obtain these as well as other supplementary case data. Of the aforementioned four published studies that reported on the incidence of cancer among siblings, supplementary data could only be retrieved from the Nordic study. 19 Additional sibships were accrued through colleagues who became aware of this international study through an editorial in Leukemia, 21 an International Society for Pediatric Oncology newsletter, or by direct contact to childhood ALL collaborative group chairs in Europe, the US and Japan. Few childhood ALL collaborative groups register data with linkage between familial cases, and register-based data could only be retrieved for patients registered in the Dutch, French, German, Nordic and the St Jude Children's Research Hospital registries.
For each case, we attempted to collect data on ethnicity, date of birth, birth weight and gestational age, birth order and total sibship size, gender, presence of leukemia-predisposing syndromes, date of diagnosis of ALL, white blood cell count (WBC) at diagnosis, the immunophenotype and karyotype of the leukemic clone (including results of FISH and/or PCR analysis for translocations t(1;19)[TCF3/PBX1], t(12;21)[ETV6/RUNX1] and t (9;22) [BCR/ABL1], and MLL aberrations) and disease status at the last follow-up. The completeness of the data for each case was influenced by the calendar period of diagnosis, the diagnostic standards of the center, the focus of published case-reports and the data source (publications, register data, or individual case reporting as part of the present study).
Statistics
As the probability of two or more cases of ALL in a sibship increases in proportion to the size of the sibship (for example, being 20-fold increase in a seven-children versus a two-children sibship assuming the same risk per child), we used the sibship-size distribution of the Danish population (http://www. statistikbanken.dk/FAM44N and http://www.dst.dk/pukora/ epub/Nyt/2004/NR186.pdf) to determine the expected frequency of sibships with two or more cases of childhood ALL, as well as the expected sibship-size distribution. Non-parametric methods were applied to compare correlations between parameters and distribution of parameters between subgroups. The distribution of clinical characteristics of the study cohort was compared with that of a population-based Nordic cohort of children with ALL. 22, 23 k-Statistics were applied to explore the concordance of ALL subtypes within the families. Projected event-free survival was estimated with the Kaplan-Meier method. 24 All statistical analysis was done with STATA 11 (StataCorp. LP, College Station, TX, USA).
Results
Of a total of 77 sibships with multiple cases of ALL reported in the literature or registered as part of this study, 23 were subsequently excluded owing to uncertain lymphoid or myeloid lineage in one or both siblings (N ¼ 5, all diagnosed before 1960), lack of data on age at diagnosis in one or both siblings (N ¼ 12) or age 418 years at diagnosis of ALL in one of the siblings (N ¼ 6). Thus, the study cohort comprised 54 sibships, 9 of which had available data only from publications (Table 1 and  references 12, 19, 30, 31, 39, 45 and 67 in Supplementary 1). Given a risk ratio of 1:2000 for developing childhood ALL before the age of 18 years, a sibship-size distribution as in Denmark and independence of risk of ALL within a sibship, letting p n be the probability of at least two ALL cases in a sibship of size n and w n be the proportion of multi-child families with n children, and Y be the total number of families required, 122 million multi-child families would be needed to obtain 54 families with at least two cases of childhood ALL, if each child was followed to the age of 18 years (54
. Even if only ALL registries were explored (that is, at least one case of childhood ALL already being diagnosed in the sibships), a total of 160 800 multi-child families would be needed in the registries, letting q n be the probability of at least two cases in a sibship of size n given one case observed, w n as the proportion of multi-child families with n children, and X as the total number of families required (that is, 54
The ethnic origin was unknown in 12 of the 54 sibships. Of the remaining 42 sibships, 2 were South American (not otherwise specified (families 34 and 50)), one was Maori (family 18), one was Japanese (family 33), one was Iranian (family 8), one was Indian (not otherwise specified (family 39)) and the remaining 36 sibships were white sibships from Australia, New Zealand, Europe or the US.
Of 46 sibships where the number of children both with and without ALL was available, 19 sibships included 3 (
children, respectively (twins being counted as one) ( Figure 1 ). Assuming that all children were followed until the age of 18 years, a cumulative risk ratio of 1:2000 for developing ALL, sibship sizes as in the Danish population and P(2 sibs|2 þ cases) þ ? þ P(7 sibs|2 þ cases) ¼ 1, 59.2% of sibships would be expected to comprise three or more siblings, that is 27.2 families were expected among the 46 families, but only 19 were observed (P ¼ 0.02). However, this may be a random finding, as the frequency of families with four or more siblings was 14 compared with the 9.5 expected (P ¼ 0.10) (Figure 1 ). Among the 19 families with a sibship size of three or more, neither the risk of the first born developing ALL nor the risk of two consecutively born children developing ALL differed significantly from the expected chance distribution ( Figure 1 ).
In one of the white sibships, one of the children with ALL had Down syndrome (Family 11, 2nd child). In another sibship from Holland of unknown ethnic origin, both ALL cases were mentally retarded, one was microcephalic and had Fanconi anemia, and the leukemic clones in both cases harbored complex karyotypes, one of which included an MLL deletion (Family 52). Finally, in one white sibship with two cases of T-cell ALL (T-ALL), the parents were first-degree cousins, and both patients harbored a heterozygous frameshift mutation in the FANCC gene (Family 26). In none of the other sibships did the children have ALL-predisposing syndromes, or their parents were related. Of 59 patients in first complete remission at the latest follow-up, 32 were o10 years of age at the time of their latest follow-up, at which age some ALL-predisposing syndromes (for example, Recklinghausen Neurofibromatosis type 1) might not have been diagnosed.
Three sibships included more than two ALL cases ( Figure 1 ). One white sibship consisted of six children with two confirmed T-ALL cases (birth order one and five) and one suspected T-ALL case (birth order two, Family 17). The three cases were diagnosed at a relatively young age for T-ALL (3.3-4.8 years), but all had enlarged livers and spleens, and their WBCs at diagnosis were 256 Â 10 9 /l, 600 Â 10 9 /l and 669 Â 10 9 /l, respectively. One Maori sibship consisted of eight children (including one set of twins) with two non-twins diagnosed with
Sibships with multiple cases of childhood ALL K Schmiegelow et al /l, respectively (Family 18). In addition, the twins were both diagnosed with ALL at 9 months of age with a WBC count of 34 Â 10 9 /l and 113 Â 10 9 /l, respectively. 25 Finally, one French sibship of unknown ethnic origin included two twin cases of T-ALL aged 3.8 and 5.8 years at diagnosis, and a non-twin half-brother with T-ALL diagnosed at 5.6 years of age (Family 21). The WBCs was only available for the two latter patients, being 49 Â 10 9 /l and 23 Â 10 9 /l, respectively. Overall, the age and WBC at diagnosis, sex, immunophenotype and karyotype distribution was similar to that found in the general population of children with ALL in Europe or the US 1, 22, 26 (Table 1) . Fifty-four percent of all cases were boys with no indication of concordance between the sexes of the first and second ALL case (P ¼ 0.90). The median gestational age (available in 28 cases) was 40 weeks, and the median birth weight (available in 32 cases) was 3500 g. The median WBC for the B-lineage-and T-lineage-ALL patients was 8 Â 10 9 /l (range, 4-41) and 150 Â 10 9 /l (range, 51-508), respectively (Po0.001). Median WBCs of the first-and second-born child with ALL were 14 Â 10 9 /l (range, 5-67) and 10 Â 10 9 /l (range, 4-83), respectively, and their WBCs were not significantly correlated (r S ¼ 0.23, P ¼ 0.11). This lack of correlation was most obvious for the 23 sibships, where both cases were confirmed to be B-lineage ALL (r S ¼ 0.10, P ¼ 0.65). The median age at diagnosis of the first-and second-born children with ALL was 6.2 years (range, 2.8-9.2) and 4.6 years (range, 3.0-6.3), respectively, and 56% of all cases were between 2.0 and 7.0 years of age. Within the families, the first-born was on average only 9 months older at diagnosis than the second-born with ALL, but the age distribution of the second-born with ALL did not differ significantly from that expected, and the slightly earlier age at diagnosis of the second-born with ALL compared with the firstborn did not reach statistical significance (data not shown). The ages at diagnosis of the first-and second-born children with ALL were significantly correlated (r S ¼ 0.41, P ¼ 0.002) (Figure 2) , which in linear correlation analyses was the case for T-ALL cases (r ¼ 0.77, P ¼ 0.13), B-lineage ALL (r ¼ 0.48, P ¼ 0.21), and for the 24 sibships with lacking information on immunophenotype (r ¼ 0.51, P ¼ 0.02). Furthermore, these correlations between the ages at diagnosis were virtually the same for the B-lineage cases, where the second-case child was born before versus after the diagnosis of the first-case child. In 30 of the 54 sibships, the firstborn case was diagnosed with ALL after the birth of the subsequent child that developed ALL.
The antibody panels applied for immunophenotyping differed between the laboratories. Accordingly, the cases were only classified as B-lineage or T-lineage. Information on the immunophenotype was available for 35 first-born and 37 second-born children, as well as for the two families with three confirmed T-ALL cases, including all but 7 of the 74 cases being diagnosed after 1987. In the 32 sibships, where the immunophenotype was available in both the cases, it was highly concordant. Using k-statistics, the expected immunophenotype concordance was 70% compared with an observed concordance of 84% (k: 0.80, Po0.0001). Notably, in five of the six sibships, where the first ALL case was T-ALL, the immunophenotype was also of T-lineage in the subsequent case (N ¼ 5) and in the third case (N ¼ 2) (Families 17, 21, 26, 53, 54) . Sibships with multiple cases of childhood ALL K Schmiegelow et al (N ¼ 1) and/or an 11q23 aberrration (N ¼ 1), only 2 sibships were karyotype-subtype discordant, whereas the other sibling in the remaining eight cases either had no karyotyping performed or had a normal G-band karyotype with no additional exploration by PCR or FISH for hyperdiploidy, t(12;21) or t(9;22).
A total of eleven sibships could be classified as ALL-subtype concordant, the cases being T-ALL (N ¼ 5, including a sibship where both harbored a SIL-TAL1 fusion gene) or B-lineage ALL sharing the same cytogenetic aberration (N ¼ 6), whereas only two were discordant by their immunophenotypes (N ¼ 2) and five B-lineage ALL sibships were discordant by their karyotypes (for example, t(12;21) versus t (1;19) ). Among the 23 families, where the concordance could not be determined owing to lack of immunophenotype and/or karyotype in one or both the cases, the ages at diagnosis (r ¼ 0.47, P ¼ 0.004) but not the WBCs (r S ¼ 0.05, P ¼ 0.80), were significantly correlated. Among the 33 families, where information on immunophenotype or cytogenetic ALL subtypes were available for both ALL siblings, there was an expected ALL-subtype agreement of 21% and an observed agreement of 67% (k: 0.58; Po0.0001). When excluding families with karyotypes classified as other or normal/missing, the expected concordance among the remaining 12 sibships was 27% and the observed concordance was 92% (k: 0.89; Po0.0001).
For the 61 patients diagnosed after 1 January 1990 and for whom follow-up data was available, the 5-year event-free survival was 0.83±0.05, with only two later events occurring at 7 years (death by car accident) and at 10 years from diagnosis (bonemarrow relapse with no further exploratory biological data).
Discussion
The present study indicates strong genetic and/or environmental risk factors for childhood ALL that, however, are restricted to specific ALL subtypes, and this must be taken into account, when performing epidemiological studies to reveal etiological factors. The pathogenesis of childhood ALL is believed to reflect rare multi-factorial combinations of genetic predispositions and environmental factors. 27 ALL encompasses a biologically heterogeneous group of diseases characterized by an incidence peak in the age group 2-7 years that is dominated by cases with a t(12;21)(p13;q22)[ETV6/RUNX1]-translocation or a highhyperdiploid karyotype (X50 chromosomes). 1, 28 A prenatal origin of the first cytogenetic aberration(s) that drive the leukemic clone has been demonstrated in [ETV6/RUNX1]-positive, high-hyperdiploid, MLL-rearranged cases and rarely in other subsets. [29] [30] [31] [32] [33] [34] [35] Even though monozygotic twins commonly share a placenta, and may exchange prenatally initiated preleukemic cells, 36 the concordance rate in twins for childhood ALL is only 10-25%, with the exception of high concordance rate in infant ALL with MLL rearrangement. 35, 37, 38 Accordingly, it has been suggested that a larger proportion of healthy newborns harbor preleukemic cells, 39 and that postnatal environmental factors influence the subsequent, often complex, malignant transformation. 2, 35, 40 However, the frequencies and levels of preleukemic cells in healthy newborns are debated. 41, 42 The present cohort of sibships with at least two cases of ALL is by far the largest published to date and provides several important findings. Furthermore, the clinical case characteristics (including karyotypes, age and WBC at diagnosis) support that conclusions drawn from the present study is likely to be relevant for understanding childhood ALL in general.
Four previously published cohort studies indicated that the risk for developing ALL among siblings to children with ALL may be increased up to twofold. [15] [16] [17] [18] [19] However, not all these studies adjusted for the type of leukemia, that is ALL versus acute myeloid leukemia. Furthermore, if sibship sizes were not taken into account, and the observed risk was increased to twofold, the true risk would increase only by 1.5 times if the sibship-size distribution for the population at risk were similar to that of the Danish population, and this increased risk would disappear completely if the fraction of sibship with three or more children were higher than 28% (calculations not shown). Just a few decades ago, and still being the case in many developing countries, the proportion of families with three or more children was far higher in Europe and the US than it is today. However, even with these reservations, can a two-fold increased risk of ALL among siblings [15] [16] [17] [18] [19] be compatible with the high ALLsubtype concordance rates of the present study? The observed concordance rate reflects the frequency of the ALL subtype in general, the frequency of the risk-associated genetic and environmental factors in the family, the likelihood that these factors increase the overall risk of ALL or the specific subtypes only, and the likelihood that other ALL subtypes will occur in these children. Simulation analyses strongly indicate that the concordance rate revealed by the present study is incompatible with the scenario that all cases of ALL in the sibships have occurred randomly or sporadic (Supplementary 2). However, the data are compatible with a very wide range of combinations of conditional disease probabilities given susceptibility and the proportion of sporadic cases of ALL. As the disease probabilities given susceptibility increase, the fraction of sporadic ALL cases tend to be small, but so does the fraction of susceptible individuals for each ALL subtype. Hence, it will be a daunting task to find gene variants associated with each ALL subtype. At the extremes of the scenarios, either the effect will be very small, or if the effect is large, then the genetic variants (for example, ATM gene alterations in patients developing T-cell ALL 43 ) or environmental exposures will be rare in the background population. These scenarios can be addressed by exploring sibships with several cases of ALL for the gene variants identified in genome-wide association studies to confirm the influence of common variants associated with low disease-probabilities, [3] [4] [5] [6] or by performing whole genome sequencing of the sibships and their parents in cases of concordant-ALL subtypes to identify rare mutations associated with high probabilities of ALL. The pathogenetic significance of the latter mutations can then be validated by investigating ALL subtype-specific odd ratios of polymorphisms in these genes, which may reveal a risk for developing childhood ALL before the age of 18 years that is far higher than the general risk ratio 1:2000.
The present study has several other critical implications for the understanding of childhood ALL.
First, the high subtype-concordance rates emphasize that exploration of the etiology of childhood ALL should be performed within biologically well-defined ALL subsets.
Second, for the many subsets of ALL that may be initiated prenatally, the high concordance rates could reflect that leukemic cells have been transferred to the mother during pregnancy 44 to rest there and later be transferred to a subsequent fetus. 45 Even though this scenario may seem unlikely, maternalfetal transmission of a BCR-ABL1-positive ALL clone has been reported 46 possibly due to immunological silencing by a chromosome-6p deletion. Furthermore, the presence of identical leukemia-associated markers (that is, clone-specific immune gene rearrangements or cytogenetic aberrations) in both ALL cases can easily be explored in sibships with concordant-ALL subtypes.
Third, a number of environmental exposures may be linked to specific subsets of leukemia and thus cause subtype concordance. Although these could include a variety of pathogenetic mechanisms, such as infections (for example, HTLV1), 47 topoisomerase-II inhibitors, 48 or low alimentary folate, 49 their relatively high prevalence in the background population may compromise their exploration in sibship studies with the exception of insertion of viral-gene sequences in the leukemia genome.
Fourth, although a maternally driven protective mechanism against recurrence of the subsets of ALL commonly initiated prenatally is not supported by the present study, 21 such a mechanism cannot be ruled out, as the previously published cohort studies [15] [16] [17] [18] [19] only reported a twofold (or less) risk of ALL among siblings, which seems to contrast (a) the statistically highly significant ALL-subtype concordance rate and (b) specifically the high concordance rate for those subsets that frequently arise prenatally (four out of the eleven concordant sibships harbored high-hyperdiploidy or t(12;21)[ETV6/ RUNX1]).
Finally, for the families that are affected by two (or more) children with ALL, it will be of some comfort to know that the cure rates in such cases do not seem to differ from those of other children with ALL.
Publication bias is unlikely to have influenced the high concordance rate, as only one of the 11 concordant-ALL subsets (T-ALL concordance) was from a single publication (reference 45 in Supplementary 1). In contrast, it cannot be excluded that the cases reported by pediatric oncologists to this study could have been biased. However, as the occurrence of a family with two or more cases of childhood ALL by itself is so uncommon that a pediatric oncologist is unlikely to encounter more than one such case during a whole career, ALL-subtype concordant cases would probably be as likely to be reported to this international study as non-concordant cases. Furthermore, even if the cytogenetic exploration of a second case of ALL in a family would specifically target the cytogenetic aberrations found in the first child, this would, if anything, reduce the underdiagnosis of subtype-concordant cases rather than leading to an overestimation of the degree of concordance.
In conclusion, the high ALL-subtype concordance within sibships strongly indicate that genetic and/or environmental risk factors for childhood ALL are restricted to specific-ALL subtypes, and this should be taken into account, when performing epidemiological studies to reveal etiological factors.
